We see the human body as the complex, interactive system that it is, with ever-changing components that affect each other
Both medications are FDA-approved for chronic weight management in adults with obesity or overweight with associated health conditions, but they work differently and produce varying results
Tirzepatide (Zepbound / Mounjaro) Tirzepatide activates both GLP-1 and GIP receptors simultaneously a dual mechanism that produces significantly greater weight loss than GLP-1 alone
Compounded semaglutide from licensed 503A pharmacies meets rigorous USP standards for sterility, potency, and puritythe same standards applied to brand-name medications
Once you have reached your weight loss goal with GLP-1 receptor agonists, you may wonder whether to continue the treatment
The brain-protective effects that may reduce dementia risk, along with improvements in sleep quality and joint pain, address multiple health concerns through a single treatment approach